重症监护康复试点项目对重症幸存者影响的随机临床试验
该前瞻性、单中心、随机试点试验纳入内科ICU住院≥48小时且预测30天同院再入院风险≥15%的成人患者,随机分为ICU康复项目组(结构化10项干预,包括住院期执业护士访视、信息手册、24小时/7天康复团队电话及由重症医师、执业护士、药师、心理师和个案管理师参与的门诊ICU康复门诊访视)与常规护理组。主要分析纳入出院存活患者,康复项目组111例、常规护理组121例,基线相似。康复项目组接受中位2项干预 vs 常规护理组1项(p<0.001)。30天内再入院:康复项目组16例(14.4%)vs 常规护理组26例(21.5%),p=0.16;再入院中位时间:康复项目组21.5天(IQR 11.5-26.2)vs 常规护理组7天(IQR 4-21.2),p=0.03;出院7天内再入院:康复项目组4例(3.6%)vs 常规护理组14例(11.6%),p=0.02;30天内死亡或再入院复合结局:康复项目组20例(18%)vs 常规护理组36例(29.8%),p=0.04。作者认为该多学科ICU康复项目较常规护理能提供更多干预,再入院时间延长的发现应在未来试验中进一步检验。
要点
- 纳入标准:内科ICU住院≥48小时、预测30天同院再入院风险≥15%的成人患者。
- 康复项目组接受中位2项干预 vs 常规护理组1项(p<0.001)。
- 30天内再入院:康复项目组16例(14.4%)vs 常规护理组26例(21.5%),p=0.16,未达统计学显著。
- 再入院中位时间:康复项目组21.5天(IQR 11.5-26.2)vs 常规护理组7天(IQR 4-21.2),p=0.03。
- 出院7天内再入院:康复项目组4例(3.6%)vs 常规护理组14例(11.6%),p=0.02;30天内死亡或再入院复合结局:康复项目组20例(18%)vs 常规护理组36例(29.8%),p=0.04。
适用人群与场景
- 成人患者,入住内科ICU至少48小时,且预测30天同院再入院风险至少15%。
诊断标准与关键阈值
- 纳入标准:内科ICU住院至少48小时,预测30天同院再入院风险至少15%。
处置流程与药物剂量
- ICU康复项目组接受结构化10项干预,包括住院期执业护士访视、信息手册、24小时/7天康复团队电话、以及由重症医师、执业护士、药师、心理师和个案管理师参与的门诊ICU康复门诊访视。
- 常规护理组的所有照护方面由治疗临床医生决定。
研究设计与关键结果
- 研究设计:前瞻性、单中心、随机试点试验,纳入出院存活患者进行分析,康复项目组n=111,常规护理组n=121,基线相似。
- 康复项目组接受中位2项干预 vs 常规护理组1项干预(p<0.001)。
- 30天内再入院:康复项目组16例(14.4%)vs 常规护理组26例(21.5%),p=0.16。
- 再入院中位时间:康复项目组21.5天(IQR 11.5-26.2)vs 常规护理组7天(IQR 4-21.2),p=0.03。
- 出院7天内再入院:康复项目组4例(3.6%)vs 常规护理组14例(11.6%),p=0.02。
- 30天内死亡或再入院复合结局:康复项目组20例(18%)vs 常规护理组36例(29.8%),p=0.04。
证据类型、等级与局限
- 证据类型:前瞻性、单中心、随机试点试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于内科ICU住院至少48小时且预测30天同院再入院风险至少15%的成人患者,ICU康复项目较常规护理能提供更多干预,并可能延长再入院时间、降低7天再入院及30天死亡或再入院复合结局;再入院时间延长的发现作者认为应在未来试验中进一步检验。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To examine the effect of an interdisciplinary ICU recovery program on process measures and clinical outcomes.
DESIGN: A prospective, single-center, randomized pilot trial.
SETTING: Academic, tertiary-care medical center.
PATIENTS: Adult patients admitted to the medical ICU for at least 48 hours with a predicted risk of 30-day same-hospital readmission of at least 15%.
INTERVENTIONS: Patients randomized to the ICU recovery program group were offered a structured 10-intervention program, including an inpatient visit by a nurse practitioner, an informational pamphlet, a 24 hours a day, 7 days a week phone number for the recovery team, and an outpatient ICU recovery clinic visit with a critical care physician, nurse practitioner, pharmacist, psychologist, and case manager. For patients randomized to the usual care group, all aspects of care were determined by treating clinicians.
MEASUREMENTS AND MAIN RESULTS: Among the primary analysis of enrolled patients who survived to hospital discharge, patients randomized to the ICU recovery program (n = 111) and usual care (n = 121) were similar at baseline. Patients in the ICU recovery program group received a median of two interventions compared with one intervention in the usual care group (p < 0.001). A total of 16 patients (14.4%) in the ICU recovery program group and 26 patients (21.5%) in the usual care group were readmitted to the study hospital within 30 days of discharge (p = 0.16). For these patients, the median time to readmission was 21.5 days (interquartile range, 11.5-26.2 d) in the ICU recovery program group and 7 days (interquartile range, 4-21.2 d) in the usual care group (p = 0.03). Four patients (3.6%) in the ICU recovery program and 14 patients (11.6%) in the usual care group were readmitted within 7 days of hospital discharge (p = 0.02). The composite outcome of death or readmission within 30 days of hospital discharge occurred in 20 patients (18%) in the ICU recovery program group and 36 patients (29.8%) in usual care group (p = 0.04).
CONCLUSIONS: This randomized pilot trial found that a multidisciplinary ICU recovery program could deliver more interventions for post ICU recovery than usual care. The finding of longer time-to-readmission with an ICU recovery program should be examined in future trials.
参考来源
- Bloom SL, Stollings JL, Kirkpatrick O, et al. Randomized Clinical Trial of an ICU Recovery Pilot Program for Survivors of Critical Illness. Crit Care Med. 2019. PMID: 31385881. doi:10.1097/CCM.0000000000003909
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。